$Fulgent Genetics (FLGT.US)$Revenue surged 12 times in 2020 ...
$Fulgent Genetics(FLGT.US$Revenue surged 12 times in 2020 and continued to grow 1.4 times in 2021. Typical epidemic stocks fell sharply by 37.6% in 2022, operating profit also reached a high of 680 million in 2021, a sharp decline of 73% in 2022, and net profit fell sharply by 72% in 2022.
Revenue fell 79% in 2023Q1, and both operating profit and net profit entered a loss range. Currently, the market value is 1.15 billion, and there is no investment value.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment